Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

3.0K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
3.0K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.0K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.0K
Lipid Catabolism01:25

Lipid Catabolism

332
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
332
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

761
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
761
Pleiotropy01:33

Pleiotropy

41.6K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
41.6K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

334
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
334

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Comprehensive Update on Pompe Disease: From Existing Therapies to Emerging Curative Strategies.

International journal of molecular sciences·2026
Same author

Twenty-Four-Hour Mean Arterial Pressure and Pulse Pressure Are Associated with Hospitalization Duration at Delivery in Pregnant Women Referred for Cardiovascular Risk Assessment.

Journal of clinical medicine·2026
Same author

Life expectancy and causes of death in classical laminopathic progeroid syndromes: systematic review with individual-patient data synthesis.

Aging·2026
Same author

Analysis of inflammatory markers in patients with abnormal circadian rhythm of blood pressure.

Archives of medical science : AMS·2026
Same author

Real-world outcomes and prognostic factors in anaplastic thyroid cancer: evidence from the REGETNE-Thyroid cohort.

The oncologist·2026
Same author

Lipodystrophies: A diagnostic and therapeutic challenge.

Endocrinologia, diabetes y nutricion·2026

Related Experiment Video

Updated: Oct 18, 2025

Fiber Type and Subcellular-Specific Analysis of Lipid Droplet Content in Skeletal Muscle
11:50

Fiber Type and Subcellular-Specific Analysis of Lipid Droplet Content in Skeletal Muscle

Published on: June 8, 2022

4.5K

Familial partial lipodystrophy syndromes.

Antía Fernández-Pombo1, Sofía Sánchez-Iglesias2, Silvia Cobelo-Gómez2

  • 1UETeM-Molecular Pathology of Rare Diseases Group, Department of Psychiatry, Radiology, Public Health, Nursing and Medicine, IDIS-CiMUS, University of Santiago de Compostela, Santiago de Compostela 15782, Spain; Division of Endocrinology and Nutrition, University Clinical Hospital of Santiago de Compostela, 15706, Spain.

Presse Medicale (Paris, France : 1983)
|October 5, 2021
PubMed
Summary

Familial partial lipodystrophy (FPLD) involves rare genetic disorders causing abnormal fat loss and accumulation. Early diagnosis and metabolic complication management are key for patient health.

More Related Videos

Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
06:08

Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Published on: May 19, 2023

2.5K
Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
09:41

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro

Published on: March 17, 2023

3.1K

Related Experiment Videos

Last Updated: Oct 18, 2025

Fiber Type and Subcellular-Specific Analysis of Lipid Droplet Content in Skeletal Muscle
11:50

Fiber Type and Subcellular-Specific Analysis of Lipid Droplet Content in Skeletal Muscle

Published on: June 8, 2022

4.5K
Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
06:08

Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Published on: May 19, 2023

2.5K
Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
09:41

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro

Published on: March 17, 2023

3.1K

Area of Science:

  • Endocrinology
  • Genetics
  • Metabolic Disorders

Background:

  • Lipodystrophies are rare genetic conditions characterized by adipose tissue loss.
  • Familial partial lipodystrophy (FPLD) syndromes present with abnormal fat distribution and significant metabolic complications like insulin resistance.
  • Current diagnostic criteria for lipodystrophy are not well-defined, complicating early identification.

Purpose of the Study:

  • To review current knowledge on FPLD syndromes.
  • To detail the clinical and molecular aspects of FPLD.
  • To outline diagnostic approaches and recent therapeutic strategies for FPLD.

Main Methods:

  • Literature review of familial partial lipodystrophy syndromes.
  • Analysis of clinical presentations and genetic mechanisms.
  • Evaluation of diagnostic clues and treatment modalities.

Main Results:

  • FPLD encompasses various autosomal dominant disorders with distinct pathogenetic mechanisms.
  • Patients experience severe metabolic complications, including insulin resistance and lipid storage issues.
  • Metreleptin, new hypoglycemic agents, and investigational drugs show promise in managing FPLD complications.

Conclusions:

  • FPLD requires careful clinical evaluation and genetic analysis for diagnosis.
  • Management focuses on controlling metabolic abnormalities.
  • Emerging therapies offer improved treatment options for FPLD patients.